RedHill Biopharma Ltd. (RDHL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.51M | -2.51M | -1.59M | -1.59M | -3.09M | -3.09M | -9.02M | -9.02M | -10.59M | -7.19M | -2.42M | -6.03M |
| Operating CF Margin % | -122.95% | -122.95% | -58.2% | -58.2% | -240.47% | -240.47% | -1589.87% | -1589.87% | -589.59% | -199.67% | -18.92% | -34.34% |
| Operating CF Growth % | 18.92% | 18.92% | 82.36% | 82.36% | 70.8% | 56.96% | -272.68% | -49.68% | 36.14% | -72.95% | 83.71% | 68.32% |
| Net Income | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M |
| Depreciation & Amortization | 84K | 84K | 100.5K | 100.5K | 209K | 209K | 202.5K | 202.5K | -58.9M | 60.48M | 2.01M | 2.09M |
| Stock-Based Compensation | 148.5K | 148.5K | 218K | 218K | 114.5K | 114.5K | 399K | 399K | 705K | 144K | 1.14M | 1.61M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -529K | -529K | 228K | 228K | -3.5M | -3.5M | 7.63M | 7.63M | 46.21M | -120.81M | -6.08M | 25.63M |
| Working Capital Changes | -144.5K | -144.5K | 451.5K | 451.5K | 1.63M | 1.63M | -3.71M | -3.71M | 638K | 2.76M | 4.24M | 342K |
| Change in Receivables | -1.41M | -1.41M | -782.5K | -782.5K | 808.5K | 808.5K | 156K | 156K | 3.95M | 27.67M | 1.49M | -2.25M |
| Change in Inventory | 241K | 241K | 76.5K | 76.5K | 292.5K | 292.5K | 275K | 275K | -3.31M | 5.15M | 1.57M | -865K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.25M | 136K | -554K | 411K |
| Cash from Investing | -2K | -2K | -4K | -4K | -500 | -500 | 5.5K | 5.5K | -7K | 0 | -8.5M | -22K |
| Capital Expenditures | -2K | -2K | -4K | -4K | -500 | -500 | -2K | -2K | -7K | 0 | -1.33K | -22K |
| CapEx % of Revenue | 0.1% | 0.1% | 0.15% | 0.15% | 0.04% | 0.04% | 0.35% | 0.35% | 0.39% | - | 0.01% | 0.13% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 7.5K | 7.5K | 0 | 0 | 1.33K | 55.67K |
| Cash from Financing | 1.63M | 1.63M | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 3K | 4.81M | 7.2M | -5.72M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -293K | -296K | -384K | -621K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.61M | 6.71M | 7.58M | -106.25K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.63M | 1.63M | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 1.91M | -1.6M | 0 | -4.99M |
| Net Change in Cash | 0 | 0 | 0 | -7.28M | 7.28M | 0 | 0 | -7M | -10.57M | -2.4M | 4.76M | -11.78M |
| Free Cash Flow | -2.51M | -2.51M | -1.6M | -1.6M | -3.09M | -3.09M | -9.02M | -9.02M | -10.6M | -7.19M | -2.42M | -6.05M |
| FCF Margin % | -123.04% | -123.04% | -58.34% | -58.34% | -240.51% | -240.51% | -1590.22% | -1590.22% | -589.98% | -199.67% | -18.93% | -34.47% |
| FCF Growth % | 18.87% | 18.87% | 82.31% | 82.31% | 70.81% | 56.96% | -272.55% | -49.17% | 36.72% | -72.41% | 83.7% | 68.23% |
| FCF per Share | -1.39 | -1.39 | -0.62 | -0.62 | -1.32 | -1.32 | -11.56 | -16.46 | -33.60 | -36.89 | -13.00 | -47.39 |
| FCF Conversion (FCF/Net Income) | 1.21x | 1.21x | 0.61x | 0.61x | 2.00x | 2.00x | 0.67x | 0.67x | -13.91x | -0.14x | 0.65x | 0.17x |
| Interest Paid | 5K | 5K | 13.5K | 13.5K | 14K | 14K | 26K | 26K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |